1 documents found
search.res_rk
Head: Сонник Євгеній Григорович. Phase III randomized (blind) for appreciating the researcher, actively controlled, multicenter efficacy and safety "ARO-EPO" compared with "proctitis" subcutaneous administration to patients with anemia due to chronic kidney disease stage 5 B, which currently receive no replacement terapibyu erythropoietin.
Ukrainian medical stomatological Academy. № 0115U001868
1 documents found
Updated: 2026-03-20
